Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Piotr Rutkowski

101-150 of 341 results

View this query on the Wikidata Query Service
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

scientific article
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

scientific article published on 26 April 2007
Combined Therapy of Gastrointestinal Stromal Tumors.

scientific article
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial

scientific article published on 08 July 2019
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib

scientific article published on 19 March 2015
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

scientific article (publication date: 2016)
Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib

scientific article
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

scientific article published on 14 November 2017
Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients

scientific article
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

scientific article published on 2 March 2017
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

scientific article published on 8 November 2013
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation

scientific article published on 11 April 2019
Epidermal growth factor receptor (EGFR) status in chordoma.

scientific article published in January 2009
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy

scientific article published on 6 November 2014
Adherence to imatinib therapy in patients with gastrointestinal stromal tumors

scientific article published on 07 August 2013
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

scientific article
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial

scientific article published on 31 March 2018
Serum markers in early-stage and locally advanced melanoma

scientific article
Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases

scientific article
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone

scientific article published on 12 October 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report

scientific article published on 16 March 2016
Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.

scientific article published on 13 April 2018
Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas

scientific article published on 20 September 2014
Current treatment options for dermatofibrosarcoma protuberans

scientific article
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications

scientific article
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 "CREATE".

scientific article published on 5 December 2017
Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma

scientific article
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

scientific article published on 11 June 2019
Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients

scientific article published on 01 December 2012
Immunotherapy of melanoma

scientific article published on 05 March 2018
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study

scholarly article by Annemiek M. van Maldegem et al published 22 September 2014 in Pediatric Blood Cancer
Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.

scientific article
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation

scientific article published on 11 July 2014
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients

scientific article published on 01 November 1999
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

scientific article published on 13 September 2018
Treatment algorithms in stage IV melanoma

scientific article published on January 2015
Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy

scientific article published on 25 March 2012
What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

scientific article
Cutaneous melanoma with nodal metastases in elderly people

scientific article published in August 2010
Nutrition and Vascular Supply of Retinal Ganglion Cells during Human Development

scientific article
Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.

scientific article published on 23 September 2016
Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact

scientific article
Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis

scientific article published on 28 June 2013
Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors

scientific article published in November 2007
Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay

scientific article published on 01 February 2001
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 01 June 2020
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 02 January 2020
The safety of regorafenib for the treatment of gastrointestinal stromal tumors

scientific article published on 11 December 2015
Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney

scientific article published in November 2007
Biomarkers of alcohol abuse. Part II. New biomarkers and their interpretation

scientific article published in January 2010

Paulina is supported by:

About Paulina

Help